SEC Form 4 · accession 0001193125-26-268202
Axsome Therapeutics, Inc. · AXSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Jeffs
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 11, 2026 · 8:34 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001579428
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 10, 2026 | S | 286 | $246.18 | D | 58,653 | D | |
| Common StockF2 | Jun 11, 2026 | S | 286 | $249.12 | D | 58,367 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed.
- F2These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025.